Theorem Clinical Research

CROs/Service Providers

AMRI's expands discovery biology offerings

Monday, September 8, 2014 01:52 PM

Albany Molecular Research (AMRI), a New York-based global CRO, has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of about 4.1% to about $9.2 billion by 2018.

More... »


PPD acquires RCT Logic's exclusive license to clinical trial design technology

Monday, September 8, 2014 01:50 PM

Pharmaceutical Product Development (PPD), a Wilmington, N.C.-based CRO, has acquired RCT Logic's exclusive license from Massachusetts General Hospital (MGH) for the portfolio of patents related to its sequential parallel comparison design (SPCD).

More... »


Almac forms academic-industry collaboration to develop green chemicals

Monday, September 8, 2014 01:48 PM

Almac, a contract development and manufacturing organization, is collaborating with Bangor University in Wales and Hockley International, a manufacturer and exporter of environmental health and industrial chemical products, on a synthetic biology project to develop novel routes to chemicals. 

More... »

DPT Laboratories acquires Meda Pharmaceuticals’ facility, retains employees

Thursday, September 4, 2014 12:21 PM

DPT Laboratories, a Texas-based contract development and manufacturing organization (CDMO) with a specialized focus on semi-solid and liquid dosage forms, has acquired Meda Pharmaceuticals’ Lakewood, N.J., facilities.

More... »

PRA Health Sciences expands in Pennsylvania

Wednesday, September 3, 2014 12:44 PM

PRA Health Science, a global CRO, is relocating Pennsylvania-based employees from its Horsham and Fort Washington locations into new office space in Blue Bell. The new office has opened and marks the first phase of PRA’s relocation plan. It soon will be PRA’s largest office worldwide.

More... »

Onyx Scientific, Cancer Research U.K. partner

Wednesday, September 3, 2014 12:30 PM

Cancer Research U.K. is using Onyx Scientific, a U.K. CRO, to manage several of its drug development projects in a bid to maximize value.

More... »

Cancer Genetics completes acquisition of BioServe India

Monday, August 25, 2014 02:06 PM

Cancer Genetics (CGI), a Rutherford, N.J.-based, DNA-based cancer diagnostics provider, has completed the acquisition of BioServe Biotechnologies, a premier genomics services provider serving the research and clinical markets in India.

More... »

Immune Targeting Systems, WCCT Global partner on influenza

Monday, August 25, 2014 02:04 PM

Immune Targeting Systems (ITS), a U.K. company specializing in the development of novel T cell immune therapies, has developed a new T cell vaccine (Flunisyn) designed to protect humans from all strains of seasonal and pandemic influenza A. ITS has sold the strain to California-based CRO WCCT Global for further development.

More... »

MMS Holdings, Oncology Trials Insights partner on oncology support services

Wednesday, August 20, 2014 01:24 PM

MMS Holdings, a Mississippi-based global CRO that focuses on regulatory submission support, and Oncology Trials Insights (OTI), a Colorado-based organization of oncology key opinion leaders that architect superior clinical trial strategies and facilitate improved decision-making, have partnered to deliver comprehensive oncology support services.

More... »

Recipharm to acquire Corvette Pharmaceutical Services Group for $159.4M

Wednesday, August 20, 2014 01:15 PM

Recipharm, a Sweden-based contract development and manufacturing organization, has signed an agreement to acquire Milan-based Corvette Pharmaceutical Services Group from Italian private equity group LBO Italia Investimenti.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 22

Roche/Genentech plans pilot trial to measure patientpreference for participating at home v. at study site

Bipartisan 21st Century Cures initiative prepares to draft legislation to accelerate biomedical R&D, lower cost

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs